Infection Related Glomerulopathy 
Introduction – Rapid Overview 
Mohammed Abdel Gawad 
Nephrology Specialist 
Alexandria – EGY 
drgawad@gmail.com 
Mansoura University – September 2014
At the beginning of the last century: 
Postulated that the disease resulted 
from antibodies that instead of having 
beneficial effects were pathogenic, an 
insight that constitutes a landmark 
that opened the field of immune-mediated 
renal disease.1 
Clemens von Pirquet
• Post-streptococal GN 
• Endocarditis associated GN 
• Shunt nephritis
• Post-streptococal GN 
• Endocarditis associated GN 
• Shunt nephritis
Post-streptococcal Glomerulonephritis 
Nephritogenic strains of group A Streptococcus pyogenes 
Streptococcal 
impetigo of M types 
47, 49, 55, and 57 
Throat infections with 
streptococcus 
types 1, 2, 4, and 12 
4–6 weeks 7–15 days 
Nephritis 
Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet 2003; 362:2095–2100.
Post-streptococcal Glomerulonephritis 
Nephritogenic strains of group A Streptococcus pyogenes 
Streptococcal 
impetigo of M types 
47, 49, 55, and 57 
Throat infections with 
streptococcus 
types 1, 2, 4, and 12 
4–6 weeks 7–15 days 
Nephritis 
Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet 2003; 362:2095–2100.
Post-streptococcal Glomerulonephritis 
Pathogenesis 
Streptococcal 
Infection 
Streptococcal 
proteinase 
exotoxin B (SPEB) 
Development of 
circulating 
immune complexes 
Deposited 
subendothelial and 
mesangial locations 
Initiate an inflammation 
(local complement activation 
and the recruitment of 
neutrophils and monocytes 
macrophages) 
Cationic antigens or 
dissociation of immune 
complexes into the 
outer aspect of the 
glomerular basement 
membrane
Post-streptococcal Glomerulonephritis 
Pathogenesis 
Streptococcal 
Infection 
Streptococcal 
proteinase 
exotoxin B (SPEB) 
Nephritis-associated 
plasmin 
receptor (NAPLr) 
A local direct mechanism of glomerular inflammatory damage 
it is not co-localized with complement or immunoglobulin 
Development of 
circulating 
immune complexes
Post-streptococcal Glomerulonephritis 
Complement Activation 
Low C3 / Normal or slightly low C4 
NAPLr 
C3Nef IgG 
antibodies 
in sera
Post-streptococcal Glomerulonephritis 
Pathology 
Diffuse endocapillary GN with proliferation 
of mesangial and endothelial cells
Post-streptococcal Glomerulonephritis 
Pathology 
Glomerular immune deposits of C3 
(100% of the cases), IgG (62%), IgM (76%)
Post-streptococcal Glomerulonephritis 
Management
Post-streptococcal Glomerulonephritis 
Management
Post-streptococcal Glomerulonephritis 
Important Clinical Points 
If decreased C3 levels lasted for more than a month (suggests 
lupus or hypocomplementemic MPGN) 
Mild proteinuria (<500 mg/day) and microscopic 
hematuria may persist for up to 1 year
• Post-streptococal GN 
• Endocarditis associated GN 
• Shunt nephritis
Endocarditis-Associated Glomerulonephritis 
Pathogenesis 
Deposition of immune complexes containing 
bacterial antigens in glomeruli, a mechanism 
similar to that proposed for PSGN.
Endocarditis-Associated Glomerulonephritis 
Complement Activation 
Low C3 / low C4
Endocarditis-Associated Glomerulonephritis 
Pathology 
Less commonly: focal GN, MN, and MPGN type I may be found.
Endocarditis 
Renal Presentation (other than GN) 
Infective 
Endocarditis 
High Cr at presentation, 
which improves on 
antibiotics 
Proteinuria/Hematuria 
Low complement 
+ve RF and cryoglobulins 
GN 
Increased Cr 
over time with 
antibiotic use 
Acute interstitial 
nephritis 
Toxic ATN 
Acute unilateral 
flank pain / 
frank hematuria 
Renal emboli
Endocarditis-Associated Glomerulonephritis 
Management
• Post-streptococal GN 
• Endocarditis associated GN 
• Shunt nephritis
Shunt Nephritis 
Infected atrioventricular shunts; this 
may occur 2 months to many years after 
insertion 
- S. Epidermidis and S. aureus 
- Less frequently Propionibacterium acnes, 
diphtheroids, Pseudomonas, or Serratia. 
ventriculoperitoneal shunts are rarely 
complicated with GN.
Shunt Nephritis 
Complement Activation 
Low C3 / low C4
Shunt Nephritis 
Pathology 
IgM, IgG, and C3 deposits are present in the glomerular capillary 
and mesangium.
Shunt Nephritis 
Management 
prompt removal of the infected atrioventricular 
shunt, which is usually replaced by 
a ventriculoperitoneal shunt.
Viral Infection Related Glomerulopathy 
General Pathogenesis 
Pathogenetic 
mechanisms 
deposition 
of 
exogenous 
immune 
complexes 
in situ 
formation 
of immune 
complexes 
autoantibody 
formation 
directed to 
endogenous 
antigen 
modified by 
viral injury 
virus-induced release 
of proinflammatory 
cytokines, chemokines, 
adhesion molecules, 
and growth factors; and 
direct cytopathic effects 
of viral proteins
Hepatitis B Virus–Associated Renal 
Disease 
HBV & The 
Kidney 
Membranous 
Nephropathy 
MPGN 
Mesangial 
Proliferative 
GN 
Polyarteritis 
Nodosa
Hepatitis B Virus–Associated Renal 
Disease 
HBV & The 
Kidney 
Membranous 
Nephropathy 
• MN may occur in chronic HBV carriers 
Mesangial 
• Nephrotic 
Proliferative 
Polyarteritis 
MPGN 
• Often have impaired Glomerulonep 
renal function 
Nodosa 
• Clinically apparent liver hritis 
disease 
• C3 and C4 levels are decreased in 20% to 50% 
• Mesangial immune deposits may also be 
present
Hepatitis B Virus–Associated Renal 
Disease 
HBV & The 
Kidney 
Membranous 
Nephropathy 
MPGN 
• Type 1 MPGN 
• the most common glomerular 
Mesangial 
Proliferative 
Glomerulonep 
hritis 
Polyarteritis 
Nodosa 
lesion in adult HBV carriers 
• Cryoglobulinemia 
• Chronic liver disease (may be 
clinically asymptomatic) 
• Nephrotic or non nephrotic 
proteinuria, often associated 
with microhematuria
Hepatitis B Virus–Associated Renal 
Disease 
HBV & The 
Kidney 
Membranous 
Nephropathy 
MPGN 
Mesangial 
Proliferative 
GN 
Polyarteritis 
Nodosa 
• IgA Deposits 
• It is a consequence of chronic 
liver disease with impaired 
clearance of IgA circulating 
immune complexes
Hepatitis C Virus–Associated Renal 
Disease 
HCV & The Kidney 
MPGN 
with or 
without 
cryoglobu 
linemia 
MN 
fibrillary 
GN 
FSGS 
(especially in 
African 
Americans) 
TMA with 
anticardiolipin 
antibodies
Hepatitis C Virus–Associated Renal 
Disease 
HCV & The Kidney 
MPGN 
with or 
without 
cryoglobu 
linemia 
MN 
fibrillary 
GN 
FSGS 
(especially in 
African 
Americans) 
TMA with 
anticardiolipin 
antibodies
Hepatitis C Virus–Associated Renal 
Disease
Hepatitis C Virus–Associated Renal Disease 
Complement Activation 
Low C3 / low C4
MPGN Classification 
According to TYPE of deposits 
Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31.
MPGN Classification 
According to TYPE of deposits 
Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31. 
No C3 
no Ig 
chronic 
phase of 
TMA
MPGN Classification 
According to TYPE of deposits 
Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31. 
No C3 
no Ig 
chronic 
phase of 
TMA 
Always check the possibility of Infection
Always suspect 
infection whatever the 
type of the deposits
Suspect any organism 
as a cause of post 
infectious MPGN 
whenever there is an 
evidence of infection
Thank You 
Mohammed Abdel Gawad

Infection Related Glomerulopathy - Introduction – Rapid Overview - Dr. Gawad

  • 1.
    Infection Related Glomerulopathy Introduction – Rapid Overview Mohammed Abdel Gawad Nephrology Specialist Alexandria – EGY drgawad@gmail.com Mansoura University – September 2014
  • 3.
    At the beginningof the last century: Postulated that the disease resulted from antibodies that instead of having beneficial effects were pathogenic, an insight that constitutes a landmark that opened the field of immune-mediated renal disease.1 Clemens von Pirquet
  • 5.
    • Post-streptococal GN • Endocarditis associated GN • Shunt nephritis
  • 6.
    • Post-streptococal GN • Endocarditis associated GN • Shunt nephritis
  • 7.
    Post-streptococcal Glomerulonephritis Nephritogenicstrains of group A Streptococcus pyogenes Streptococcal impetigo of M types 47, 49, 55, and 57 Throat infections with streptococcus types 1, 2, 4, and 12 4–6 weeks 7–15 days Nephritis Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet 2003; 362:2095–2100.
  • 8.
    Post-streptococcal Glomerulonephritis Nephritogenicstrains of group A Streptococcus pyogenes Streptococcal impetigo of M types 47, 49, 55, and 57 Throat infections with streptococcus types 1, 2, 4, and 12 4–6 weeks 7–15 days Nephritis Poynard T, Yuen MF, Ratziu V et al. Viral hepatitis C. Lancet 2003; 362:2095–2100.
  • 9.
    Post-streptococcal Glomerulonephritis Pathogenesis Streptococcal Infection Streptococcal proteinase exotoxin B (SPEB) Development of circulating immune complexes Deposited subendothelial and mesangial locations Initiate an inflammation (local complement activation and the recruitment of neutrophils and monocytes macrophages) Cationic antigens or dissociation of immune complexes into the outer aspect of the glomerular basement membrane
  • 10.
    Post-streptococcal Glomerulonephritis Pathogenesis Streptococcal Infection Streptococcal proteinase exotoxin B (SPEB) Nephritis-associated plasmin receptor (NAPLr) A local direct mechanism of glomerular inflammatory damage it is not co-localized with complement or immunoglobulin Development of circulating immune complexes
  • 11.
    Post-streptococcal Glomerulonephritis ComplementActivation Low C3 / Normal or slightly low C4 NAPLr C3Nef IgG antibodies in sera
  • 12.
    Post-streptococcal Glomerulonephritis Pathology Diffuse endocapillary GN with proliferation of mesangial and endothelial cells
  • 13.
    Post-streptococcal Glomerulonephritis Pathology Glomerular immune deposits of C3 (100% of the cases), IgG (62%), IgM (76%)
  • 14.
  • 15.
  • 16.
    Post-streptococcal Glomerulonephritis ImportantClinical Points If decreased C3 levels lasted for more than a month (suggests lupus or hypocomplementemic MPGN) Mild proteinuria (<500 mg/day) and microscopic hematuria may persist for up to 1 year
  • 17.
    • Post-streptococal GN • Endocarditis associated GN • Shunt nephritis
  • 18.
    Endocarditis-Associated Glomerulonephritis Pathogenesis Deposition of immune complexes containing bacterial antigens in glomeruli, a mechanism similar to that proposed for PSGN.
  • 19.
  • 20.
    Endocarditis-Associated Glomerulonephritis Pathology Less commonly: focal GN, MN, and MPGN type I may be found.
  • 21.
    Endocarditis Renal Presentation(other than GN) Infective Endocarditis High Cr at presentation, which improves on antibiotics Proteinuria/Hematuria Low complement +ve RF and cryoglobulins GN Increased Cr over time with antibiotic use Acute interstitial nephritis Toxic ATN Acute unilateral flank pain / frank hematuria Renal emboli
  • 22.
  • 23.
    • Post-streptococal GN • Endocarditis associated GN • Shunt nephritis
  • 24.
    Shunt Nephritis Infectedatrioventricular shunts; this may occur 2 months to many years after insertion - S. Epidermidis and S. aureus - Less frequently Propionibacterium acnes, diphtheroids, Pseudomonas, or Serratia. ventriculoperitoneal shunts are rarely complicated with GN.
  • 25.
    Shunt Nephritis ComplementActivation Low C3 / low C4
  • 26.
    Shunt Nephritis Pathology IgM, IgG, and C3 deposits are present in the glomerular capillary and mesangium.
  • 27.
    Shunt Nephritis Management prompt removal of the infected atrioventricular shunt, which is usually replaced by a ventriculoperitoneal shunt.
  • 29.
    Viral Infection RelatedGlomerulopathy General Pathogenesis Pathogenetic mechanisms deposition of exogenous immune complexes in situ formation of immune complexes autoantibody formation directed to endogenous antigen modified by viral injury virus-induced release of proinflammatory cytokines, chemokines, adhesion molecules, and growth factors; and direct cytopathic effects of viral proteins
  • 30.
    Hepatitis B Virus–AssociatedRenal Disease HBV & The Kidney Membranous Nephropathy MPGN Mesangial Proliferative GN Polyarteritis Nodosa
  • 31.
    Hepatitis B Virus–AssociatedRenal Disease HBV & The Kidney Membranous Nephropathy • MN may occur in chronic HBV carriers Mesangial • Nephrotic Proliferative Polyarteritis MPGN • Often have impaired Glomerulonep renal function Nodosa • Clinically apparent liver hritis disease • C3 and C4 levels are decreased in 20% to 50% • Mesangial immune deposits may also be present
  • 32.
    Hepatitis B Virus–AssociatedRenal Disease HBV & The Kidney Membranous Nephropathy MPGN • Type 1 MPGN • the most common glomerular Mesangial Proliferative Glomerulonep hritis Polyarteritis Nodosa lesion in adult HBV carriers • Cryoglobulinemia • Chronic liver disease (may be clinically asymptomatic) • Nephrotic or non nephrotic proteinuria, often associated with microhematuria
  • 33.
    Hepatitis B Virus–AssociatedRenal Disease HBV & The Kidney Membranous Nephropathy MPGN Mesangial Proliferative GN Polyarteritis Nodosa • IgA Deposits • It is a consequence of chronic liver disease with impaired clearance of IgA circulating immune complexes
  • 34.
    Hepatitis C Virus–AssociatedRenal Disease HCV & The Kidney MPGN with or without cryoglobu linemia MN fibrillary GN FSGS (especially in African Americans) TMA with anticardiolipin antibodies
  • 35.
    Hepatitis C Virus–AssociatedRenal Disease HCV & The Kidney MPGN with or without cryoglobu linemia MN fibrillary GN FSGS (especially in African Americans) TMA with anticardiolipin antibodies
  • 36.
  • 37.
    Hepatitis C Virus–AssociatedRenal Disease Complement Activation Low C3 / low C4
  • 38.
    MPGN Classification Accordingto TYPE of deposits Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31.
  • 39.
    MPGN Classification Accordingto TYPE of deposits Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31. No C3 no Ig chronic phase of TMA
  • 40.
    MPGN Classification Accordingto TYPE of deposits Algorithm source: Sanjeev Sethi et al. N Engl J Med 2012;366:1119-31. No C3 no Ig chronic phase of TMA Always check the possibility of Infection
  • 42.
    Always suspect infectionwhatever the type of the deposits
  • 44.
    Suspect any organism as a cause of post infectious MPGN whenever there is an evidence of infection
  • 46.
    Thank You MohammedAbdel Gawad